|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000142611 |
Summary for PRDM16 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000142611 | Gene symbol | PRDM16 |
| Gene name | PR/SET domain 16 | |
| HGNC | 14000 | |
| Entrez ID | 63976 | |
| Gene type | protein_coding | |
| Synonyms | PRDM16|MEL1|PFM13|KIAA1675|MGC166915|KMT8F | |
| UniProtAcc | Q9HAZ2 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PRDM16 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PRDM16 | 6.96e+02 | -1.05e+00 | 3.44e-01 | -3.06e+00 | 2.19e-03 | 4.41e-03 | LUAD |
| PRDM16 | 1.09e+03 | -2.30e+00 | 6.79e-01 | -3.39e+00 | 6.89e-04 | 4.73e-03 | ESCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PRDM16 | 1.08e+03 | -1.32e+00 | 4.34e-01 | -3.03e+00 | 2.45e-03 | 1.13e-02 | STAD |
Top |
Sex-biased somatic mutation for PRDM16 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PRDM16 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg05303132 | chr1:3068067 | CGI:chr1:3067361-3071398 | promoter | 3.09e-01 | 4.99e-01 | -2.17e+00 | 3.01e-02 | 4.10e-02 | -1.90e-01 |
| BRCA | cg17239558 | chr1:3070768 | CGI:chr1:3067361-3071398 | promoter,gene body | 2.52e-01 | 4.18e-01 | -2.23e+00 | 2.58e-02 | 3.86e-02 | -1.67e-01 |
| BRCA | cg17173498 | chr1:3068930 | CGI:chr1:3067361-3071398 | promoter | 1.68e-01 | 3.92e-01 | -2.47e+00 | 1.36e-02 | 3.00e-02 | -2.23e-01 |
| BRCA | cg26938364 | chr1:3068963 | CGI:chr1:3067361-3071398 | promoter | 1.42e-01 | 4.48e-01 | -1.99e+00 | 4.67e-02 | 4.87e-02 | -3.06e-01 |
| BRCA | cg25152368 | chr1:3069128 | CGI:chr1:3067361-3071398 | promoter | 1.69e-01 | 4.57e-01 | -2.18e+00 | 2.90e-02 | 4.04e-02 | -2.87e-01 |
| BRCA | cg12267948 | chr1:3070002 | CGI:chr1:3067361-3071398 | promoter,gene body | 1.17e-01 | 3.87e-01 | -2.30e+00 | 2.16e-02 | 3.60e-02 | -2.70e-01 |
| BRCA | cg10802480 | chr1:3067691 | CGI:chr1:3067361-3071398 | promoter | 3.86e-01 | 5.22e-01 | -1.97e+00 | 4.85e-02 | 4.94e-02 | -1.36e-01 |
| BRCA | cg07363855 | chr1:3067906 | CGI:chr1:3067361-3071398 | promoter | 4.61e-01 | 5.90e-01 | -2.32e+00 | 2.03e-02 | 3.52e-02 | -1.29e-01 |
| BRCA | cg08528984 | chr1:3068654 | CGI:chr1:3067361-3071398 | promoter | 3.91e-01 | 6.17e-01 | -2.41e+00 | 1.60e-02 | 3.21e-02 | -2.26e-01 |
| BRCA | cg04080595 | chr1:3069085 | CGI:chr1:3067361-3071398 | promoter | 2.76e-01 | 4.36e-01 | -2.74e+00 | 6.23e-03 | 2.22e-02 | -1.60e-01 |
| BRCA | cg08541612 | chr1:3069156 | CGI:chr1:3067361-3071398 | promoter | 1.86e-01 | 4.50e-01 | -2.07e+00 | 3.82e-02 | 4.51e-02 | -2.64e-01 |
| BRCA | cg08537652 | chr1:3069798 | CGI:chr1:3067361-3071398 | promoter,gene body | 1.25e-01 | 2.77e-01 | -2.16e+00 | 3.06e-02 | 4.14e-02 | -1.52e-01 |
| BRCA | cg07534194 | chr1:3070783 | CGI:chr1:3067361-3071398 | promoter,gene body | 3.98e-01 | 5.53e-01 | -2.20e+00 | 2.77e-02 | 3.97e-02 | -1.55e-01 |
| LAML | cg12140144 | chr1:3067711 | CGI:chr1:3067361-3071398 | promoter | 2.27e-01 | 3.30e-01 | -2.04e+00 | 4.18e-02 | 4.69e-02 | -1.04e-01 |
| CHOL | cg12140144 | chr1:3067711 | CGI:chr1:3067361-3071398 | promoter | 5.09e-01 | 2.73e-01 | 2.99e+00 | 2.77e-03 | 8.11e-03 | 2.36e-01 |
| CHOL | cg04241652 | chr1:3068266 | CGI:chr1:3067361-3071398 | promoter | 2.82e-01 | 1.21e-01 | 1.97e+00 | 4.84e-02 | 4.84e-02 | 1.60e-01 |
| CHOL | cg07946633 | chr1:3067681 | CGI:chr1:3067361-3071398 | promoter | 6.06e-01 | 4.86e-01 | 2.39e+00 | 1.70e-02 | 2.98e-02 | 1.21e-01 |
| CHOL | cg10802480 | chr1:3067691 | CGI:chr1:3067361-3071398 | promoter | 5.12e-01 | 3.71e-01 | 2.48e+00 | 1.30e-02 | 2.54e-02 | 1.41e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg12140144 | chr1:3067711 | CGI:chr1:3067361-3071398 | promoter | 1.57e-01 | 3.20e-02 | 6.18e+00 | 6.26e-10 | 8.59e-09 | 1.25e-01 |
| KIRC | cg05303132 | chr1:3068067 | CGI:chr1:3067361-3071398 | promoter | 1.66e-01 | 5.15e-02 | 5.00e+00 | 5.64e-07 | 2.21e-06 | 1.15e-01 |
| KIRC | cg19356825 | chr1:3068748 | CGI:chr1:3067361-3071398 | promoter | 1.38e-01 | 9.37e-03 | 5.93e+00 | 3.04e-09 | 2.81e-08 | 1.28e-01 |
| KIRC | cg07946633 | chr1:3067681 | CGI:chr1:3067361-3071398 | promoter | 3.82e-01 | 2.66e-01 | 6.11e+00 | 9.96e-10 | 1.20e-08 | 1.16e-01 |
| KIRC | cg10802480 | chr1:3067691 | CGI:chr1:3067361-3071398 | promoter | 2.55e-01 | 1.26e-01 | 6.55e+00 | 5.79e-11 | 1.97e-09 | 1.29e-01 |
| KIRC | cg08528984 | chr1:3068654 | CGI:chr1:3067361-3071398 | promoter | 2.30e-01 | 1.19e-01 | 4.71e+00 | 2.50e-06 | 8.09e-06 | 1.11e-01 |
| KIRC | cg04080595 | chr1:3069085 | CGI:chr1:3067361-3071398 | promoter | 2.22e-01 | 1.17e-01 | 5.62e+00 | 1.92e-08 | 1.24e-07 | 1.05e-01 |
| KIRC | cg07534194 | chr1:3070783 | CGI:chr1:3067361-3071398 | promoter,gene body | 2.13e-01 | 8.88e-02 | 5.08e+00 | 3.69e-07 | 1.53e-06 | 1.25e-01 |
| LUAD | cg04241652 | chr1:3068266 | CGI:chr1:3067361-3071398 | promoter | 1.49e-01 | 3.31e-02 | 4.35e+00 | 1.34e-05 | 5.35e-05 | 1.16e-01 |
| LUAD | cg01908338 | chr1:3067961 | CGI:chr1:3067361-3071398 | promoter | 2.05e-01 | 9.86e-02 | 4.41e+00 | 1.02e-05 | 4.26e-05 | 1.07e-01 |
| HNSC | cg17239558 | chr1:3070768 | CGI:chr1:3067361-3071398 | promoter,gene body | 1.64e-01 | 4.27e-02 | 2.98e+00 | 2.87e-03 | 4.44e-03 | 1.21e-01 |
| HNSC | cg00945293 | chr1:3068305 | CGI:chr1:3067361-3071398 | promoter | 1.92e-01 | 2.37e-02 | 3.88e+00 | 1.04e-04 | 2.68e-04 | 1.69e-01 |
| HNSC | cg07534194 | chr1:3070783 | CGI:chr1:3067361-3071398 | promoter,gene body | 3.01e-01 | 1.71e-01 | 3.18e+00 | 1.47e-03 | 2.51e-03 | 1.30e-01 |
| LUSC | cg12140144 | chr1:3067711 | CGI:chr1:3067361-3071398 | promoter | 3.32e-01 | 4.09e-02 | 4.19e+00 | 2.82e-05 | 5.26e-04 | 2.91e-01 |
| LUSC | cg05303132 | chr1:3068067 | CGI:chr1:3067361-3071398 | promoter | 2.04e-01 | 4.91e-02 | 3.63e+00 | 2.87e-04 | 1.19e-03 | 1.55e-01 |
| LUSC | cg04241652 | chr1:3068266 | CGI:chr1:3067361-3071398 | promoter | 1.45e-01 | 2.58e-02 | 3.95e+00 | 7.91e-05 | 6.37e-04 | 1.19e-01 |
| LUSC | cg11229543 | chr1:3067881 | CGI:chr1:3067361-3071398 | promoter | 4.40e-01 | 8.50e-02 | 4.20e+00 | 2.65e-05 | 5.26e-04 | 3.55e-01 |
| LUSC | cg18381051 | chr1:3071081 | CGI:chr1:3067361-3071398 | promoter,gene body | 3.46e-01 | 2.90e-02 | 4.00e+00 | 6.36e-05 | 5.92e-04 | 3.17e-01 |
| LUSC | cg07946633 | chr1:3067681 | CGI:chr1:3067361-3071398 | promoter | 5.05e-01 | 3.24e-01 | 4.06e+00 | 5.00e-05 | 5.58e-04 | 1.81e-01 |
| LUSC | cg10802480 | chr1:3067691 | CGI:chr1:3067361-3071398 | promoter | 3.32e-01 | 1.55e-01 | 4.27e+00 | 1.98e-05 | 5.26e-04 | 1.77e-01 |
| LUSC | cg07363855 | chr1:3067906 | CGI:chr1:3067361-3071398 | promoter | 4.01e-01 | 1.47e-01 | 4.16e+00 | 3.19e-05 | 5.26e-04 | 2.54e-01 |
| LUSC | cg01908338 | chr1:3067961 | CGI:chr1:3067361-3071398 | promoter | 2.23e-01 | 9.44e-02 | 3.84e+00 | 1.21e-04 | 7.60e-04 | 1.29e-01 |
| LUSC | cg07534194 | chr1:3070783 | CGI:chr1:3067361-3071398 | promoter,gene body | 2.08e-01 | 9.20e-02 | 3.94e+00 | 8.07e-05 | 6.42e-04 | 1.16e-01 |
| COAD | cg17239558 | chr1:3070768 | CGI:chr1:3067361-3071398 | promoter,gene body | 2.24e-01 | 3.44e-02 | 2.72e+00 | 6.62e-03 | 1.03e-02 | 1.89e-01 |
| BLCA | cg12140144 | chr1:3067711 | CGI:chr1:3067361-3071398 | promoter | 4.06e-01 | 8.66e-02 | 3.84e+00 | 1.25e-04 | 4.71e-04 | 3.20e-01 |
| BLCA | cg05303132 | chr1:3068067 | CGI:chr1:3067361-3071398 | promoter | 4.00e-01 | 1.33e-01 | 2.96e+00 | 3.04e-03 | 5.47e-03 | 2.68e-01 |
| BLCA | cg17239558 | chr1:3070768 | CGI:chr1:3067361-3071398 | promoter,gene body | 2.23e-01 | 4.40e-02 | 2.42e+00 | 1.57e-02 | 2.02e-02 | 1.79e-01 |
| BLCA | cg00945293 | chr1:3068305 | CGI:chr1:3067361-3071398 | promoter | 3.28e-01 | 4.83e-02 | 2.83e+00 | 4.72e-03 | 7.77e-03 | 2.80e-01 |
| BLCA | cg07946633 | chr1:3067681 | CGI:chr1:3067361-3071398 | promoter | 5.31e-01 | 3.67e-01 | 3.78e+00 | 1.55e-04 | 5.49e-04 | 1.64e-01 |
| BLCA | cg10802480 | chr1:3067691 | CGI:chr1:3067361-3071398 | promoter | 3.84e-01 | 1.95e-01 | 3.89e+00 | 9.98e-05 | 3.99e-04 | 1.89e-01 |
| BLCA | cg01908338 | chr1:3067961 | CGI:chr1:3067361-3071398 | promoter | 3.30e-01 | 1.54e-01 | 2.42e+00 | 1.54e-02 | 1.99e-02 | 1.76e-01 |
| ESCA | cg12140144 | chr1:3067711 | CGI:chr1:3067361-3071398 | promoter | 3.26e-01 | 1.07e-01 | 2.53e+00 | 1.14e-02 | 3.68e-02 | 2.19e-01 |
| ESCA | cg11229543 | chr1:3067881 | CGI:chr1:3067361-3071398 | promoter | 4.11e-01 | 1.84e-01 | 2.24e+00 | 2.49e-02 | 4.21e-02 | 2.27e-01 |
| ESCA | cg18381051 | chr1:3071081 | CGI:chr1:3067361-3071398 | promoter,gene body | 3.91e-01 | 1.74e-01 | 1.98e+00 | 4.82e-02 | 4.90e-02 | 2.17e-01 |
| ESCA | cg07946633 | chr1:3067681 | CGI:chr1:3067361-3071398 | promoter | 4.96e-01 | 3.60e-01 | 2.48e+00 | 1.31e-02 | 3.74e-02 | 1.36e-01 |
| ESCA | cg10802480 | chr1:3067691 | CGI:chr1:3067361-3071398 | promoter | 3.40e-01 | 2.20e-01 | 2.37e+00 | 1.77e-02 | 3.94e-02 | 1.20e-01 |
| ESCA | cg07363855 | chr1:3067906 | CGI:chr1:3067361-3071398 | promoter | 3.98e-01 | 2.23e-01 | 2.23e+00 | 2.55e-02 | 4.23e-02 | 1.74e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg12140144 | chr1:3067711 | CGI:chr1:3067361-3071398 | promoter | 3.90e-01 | 1.67e-01 | 9.21e+00 | 3.15e-20 | 1.74e-19 | 2.23e-01 |
| BRCA | cg05303132 | chr1:3068067 | CGI:chr1:3067361-3071398 | promoter | 3.09e-01 | 8.23e-02 | 9.44e+00 | 3.75e-21 | 2.24e-20 | 2.27e-01 |
| BRCA | cg04241652 | chr1:3068266 | CGI:chr1:3067361-3071398 | promoter | 3.09e-01 | 4.01e-02 | 1.13e+01 | 1.02e-29 | 1.43e-28 | 2.69e-01 |
| BRCA | cg17239558 | chr1:3070768 | CGI:chr1:3067361-3071398 | promoter,gene body | 2.52e-01 | 3.95e-02 | 1.09e+01 | 7.88e-28 | 8.92e-27 | 2.12e-01 |
| BRCA | cg11229543 | chr1:3067881 | CGI:chr1:3067361-3071398 | promoter | 4.37e-01 | 1.64e-01 | 1.06e+01 | 2.87e-26 | 2.76e-25 | 2.73e-01 |
| BRCA | cg00945293 | chr1:3068305 | CGI:chr1:3067361-3071398 | promoter | 2.49e-01 | 2.61e-02 | 9.75e+00 | 1.82e-22 | 1.22e-21 | 2.23e-01 |
| BRCA | cg19356825 | chr1:3068748 | CGI:chr1:3067361-3071398 | promoter | 2.76e-01 | 3.27e-02 | 9.87e+00 | 5.75e-23 | 4.04e-22 | 2.43e-01 |
| BRCA | cg17173498 | chr1:3068930 | CGI:chr1:3067361-3071398 | promoter | 1.68e-01 | 1.54e-02 | 8.99e+00 | 2.55e-19 | 1.30e-18 | 1.53e-01 |
| BRCA | cg26938364 | chr1:3068963 | CGI:chr1:3067361-3071398 | promoter | 1.42e-01 | 1.91e-02 | 8.02e+00 | 1.09e-15 | 4.19e-15 | 1.22e-01 |
| BRCA | cg07348009 | chr1:3069125 | CGI:chr1:3067361-3071398 | promoter | 2.10e-01 | 4.81e-02 | 9.82e+00 | 9.20e-23 | 6.34e-22 | 1.62e-01 |
| BRCA | cg25152368 | chr1:3069128 | CGI:chr1:3067361-3071398 | promoter | 1.69e-01 | 4.02e-02 | 6.08e+00 | 1.17e-09 | 2.84e-09 | 1.29e-01 |
| BRCA | cg12267948 | chr1:3070002 | CGI:chr1:3067361-3071398 | promoter,gene body | 1.17e-01 | 1.34e-02 | 9.05e+00 | 1.39e-19 | 7.24e-19 | 1.04e-01 |
| BRCA | cg10802480 | chr1:3067691 | CGI:chr1:3067361-3071398 | promoter | 3.86e-01 | 2.04e-01 | 1.11e+01 | 9.83e-29 | 1.23e-27 | 1.82e-01 |
| BRCA | cg07363855 | chr1:3067906 | CGI:chr1:3067361-3071398 | promoter | 4.61e-01 | 2.56e-01 | 1.06e+01 | 2.84e-26 | 2.74e-25 | 2.05e-01 |
| BRCA | cg01908338 | chr1:3067961 | CGI:chr1:3067361-3071398 | promoter | 2.42e-01 | 1.26e-01 | 6.51e+00 | 7.62e-11 | 2.02e-10 | 1.17e-01 |
| BRCA | cg08528984 | chr1:3068654 | CGI:chr1:3067361-3071398 | promoter | 3.91e-01 | 1.56e-01 | 1.05e+01 | 5.26e-26 | 4.93e-25 | 2.35e-01 |
| BRCA | cg04080595 | chr1:3069085 | CGI:chr1:3067361-3071398 | promoter | 2.76e-01 | 1.37e-01 | 7.97e+00 | 1.60e-15 | 6.06e-15 | 1.39e-01 |
| BRCA | cg08541612 | chr1:3069156 | CGI:chr1:3067361-3071398 | promoter | 1.86e-01 | 6.56e-02 | 6.87e+00 | 6.42e-12 | 1.85e-11 | 1.21e-01 |
| BRCA | cg13744917 | chr1:3069974 | CGI:chr1:3067361-3071398 | promoter,gene body | 1.57e-01 | 4.11e-02 | 7.69e+00 | 1.49e-14 | 5.25e-14 | 1.16e-01 |
| BRCA | cg07534194 | chr1:3070783 | CGI:chr1:3067361-3071398 | promoter,gene body | 3.98e-01 | 1.71e-01 | 1.06e+01 | 2.06e-26 | 2.01e-25 | 2.27e-01 |
| COAD | cg25152368 | chr1:3069128 | CGI:chr1:3067361-3071398 | promoter | 1.66e-01 | 3.01e-02 | 3.46e+00 | 5.37e-04 | 1.93e-03 | 1.35e-01 |
| COAD | cg12267948 | chr1:3070002 | CGI:chr1:3067361-3071398 | promoter,gene body | 1.23e-01 | 1.43e-02 | 2.14e+00 | 3.21e-02 | 3.64e-02 | 1.09e-01 |
| LIHC | cg07363855 | chr1:3067906 | CGI:chr1:3067361-3071398 | promoter | 4.16e-01 | 2.67e-01 | 2.52e+00 | 1.19e-02 | 1.59e-02 | 1.49e-01 |
| KIRP | cg07534194 | chr1:3070783 | CGI:chr1:3067361-3071398 | promoter,gene body | 2.04e-01 | 9.57e-02 | 2.22e+00 | 2.67e-02 | 3.25e-02 | 1.08e-01 |
Top |
Exon skipping events with PSI in TCGA for PRDM16 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for PRDM16 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PRDM16 |
| TFs related to PRDM16. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| PRDM16 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PRDM16 |
| RBPs related to ES in PRDM16. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| PRDM16 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000142611 | KCNQ1OT1,hsa-mir-133b,PRDM16 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000142611 | SNHG14,hsa-mir-133b,PRDM16 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000142611 | KCNQ1OT1,hsa-mir-296,PRDM16 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000142611 | SNHG14,hsa-mir-296,PRDM16 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000142611 | C5orf66-AS1,hsa-mir-296,PRDM16 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000142611 | KCNQ1OT1,hsa-mir-330,PRDM16 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000142611 | AC068790.5,hsa-mir-330,PRDM16 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000142611 | KCNQ1OT1,hsa-mir-409,PRDM16 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000142611 | KCNQ1OT1,hsa-mir-429,PRDM16 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000142611 | SNHG14,hsa-mir-429,PRDM16 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000142611 | Z95331.1,hsa-mir-429,PRDM16 | Female-specific ceRNA | TCGA-LIHC |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs11121559 | chr1:10395091:G:A | - | 0.1721789093748 | 0.0130991318496581 | PAAD | Female-baised eQTL |
| rs6702309 | chr1:7019197:G:T | - | 0.221564316672174 | 0.0405862995005246 | GBM | Female-baised eQTL |
| rs201613528 | chr1:7498838:G:A | - | 0.178637974087567 | 8.06441794476187e-15 | LGG | Female-baised eQTL |
| rs61772234 | chr1:7488601:T:C | - | 0.178216828372369 | 1.01254034046069e-14 | LGG | Female-baised eQTL |
| rs61111144 | chr1:7492374:G:C | - | 0.172601191380902 | 6.39456954209494e-14 | LGG | Female-baised eQTL |
| rs10864304 | chr1:7497092:A:G | - | 0.12788872609991 | 1.93225209182721e-09 | LGG | Female-baised eQTL |
| rs4328022 | chr1:3477715:C:T | - | 0.112823356456325 | 6.11011156963283e-06 | LGG | Female-baised eQTL |
| rs61734742 | chr1:3478610:C:A | - | 0.112823356456325 | 6.11011156963283e-06 | LGG | Female-baised eQTL |
| rs2493315 | chr1:3483278:G:A | - | 0.11274663923278 | 6.32291858897245e-06 | LGG | Female-baised eQTL |
| rs57077909 | chr1:7492441:A:T | - | 0.0965088902325372 | 9.37037824476913e-06 | LGG | Female-baised eQTL |
| rs72644730 | chr1:5862070:C:T | - | 0.100243439343298 | 1.12272958389805e-05 | LGG | Female-baised eQTL |
| rs3931607 | chr1:3455668:C:T | - | 0.0950617278613912 | 5.67740988741936e-05 | LGG | Female-baised eQTL |
| rs56293443 | chr1:5864821:G:A | - | 0.0923504233823846 | 7.41503437684975e-05 | LGG | Female-baised eQTL |
| rs75368965 | chr1:3455298:T:A | - | 0.0867398886406893 | 0.000323054701395076 | LGG | Female-baised eQTL |
| rs77136906 | chr1:3455299:C:A | - | 0.0867398886406893 | 0.000323054701395076 | LGG | Female-baised eQTL |
| rs11121605 | chr1:5861525:T:A | - | 0.0841884216164311 | 0.000478970509212789 | LGG | Female-baised eQTL |
| rs56127510 | chr1:5952130:A:G | - | 0.0822782635197396 | 0.000638166284660174 | LGG | Female-baised eQTL |
| rs11121423 | chr1:9450467:T:C | - | -0.0834569322753203 | 0.000931567805841008 | LGG | Female-baised eQTL |
| rs72630630 | chr1:5937622:C:T | - | 0.0761474453069416 | 0.00120435406637632 | LGG | Female-baised eQTL |
| rs10864423 | chr1:9449961:A:G | - | -0.0793343993641058 | 0.0018649105181201 | LGG | Female-baised eQTL |
| rs2062784 | chr1:5940069:T:C | - | 0.0740182224667078 | 0.00201169785743932 | LGG | Female-baised eQTL |
| rs12409002 | chr1:5973271:T:C | - | 0.0762221106215704 | 0.00218386809980491 | LGG | Female-baised eQTL |
| rs7522246 | chr1:5963559:T:C | - | 0.0761014917720205 | 0.00219244606457718 | LGG | Female-baised eQTL |
| rs10157281 | chr1:5855602:G:A | - | 0.075151077168448 | 0.00266085090265123 | LGG | Female-baised eQTL |
| rs1220382 | chr1:9899690:C:T | - | 0.0690190246472525 | 0.00403431060515623 | LGG | Female-baised eQTL |
| rs144096630 | chr1:4666965:C:T | - | 0.12258269533677 | 0.00443440554685664 | LGG | Female-baised eQTL |
| rs76508223 | chr1:4667197:C:T | - | 0.12258269533677 | 0.00443440554685664 | LGG | Female-baised eQTL |
| rs7225 | chr1:9848622:C:T | - | 0.0693240463999544 | 0.00443790179297297 | LGG | Female-baised eQTL |
| rs1470160 | chr1:9870199:G:A | - | 0.0680482452128146 | 0.00502456096270221 | LGG | Female-baised eQTL |
| rs1660735 | chr1:9885480:C:T | - | 0.0680482452128146 | 0.00502456096270221 | LGG | Female-baised eQTL |
| rs1220413 | chr1:9867196:A:G | - | 0.0682315680422818 | 0.0053846969423495 | LGG | Female-baised eQTL |
| rs935074 | chr1:9869909:G:A | - | 0.0682315680422818 | 0.0053846969423495 | LGG | Female-baised eQTL |
| rs1220406 | chr1:9862372:C:T | - | 0.0677737364570273 | 0.00568652439507486 | LGG | Female-baised eQTL |
| rs11588169 | chr1:4665568:C:T | - | 0.118632802258694 | 0.00594994863272307 | LGG | Female-baised eQTL |
| rs17455108 | chr1:4663988:A:G | - | 0.118224001025468 | 0.00630827331551423 | LGG | Female-baised eQTL |
| rs76789200 | chr1:4659026:C:T | - | 0.118203146580946 | 0.00634983786792636 | LGG | Female-baised eQTL |
| rs12733769 | chr1:3997342:T:A | - | 0.0637132892088654 | 0.0106486701869746 | LGG | Female-baised eQTL |
| rs1220394 | chr1:9849448:G:A | - | 0.0640679946502428 | 0.0114964452385166 | LGG | Female-baised eQTL |
| rs12404173 | chr1:4958018:C:T | - | 0.0998356313237154 | 0.0119135595946886 | LGG | Female-baised eQTL |
| rs11576910 | chr1:5910205:G:A | - | 0.0647254853992455 | 0.0121524716287493 | LGG | Female-baised eQTL |
| rs1220395 | chr1:9848211:C:T | - | 0.063945147004823 | 0.012513239610383 | LGG | Female-baised eQTL |
| rs1220418 | chr1:9878761:C:T | - | 0.0639344219543815 | 0.0134653176609097 | LGG | Female-baised eQTL |
| rs935075 | chr1:9882060:C:T | - | 0.0633234007804983 | 0.0151346560256289 | LGG | Female-baised eQTL |
| rs1220384 | chr1:9896127:C:A | - | 0.0633234007804983 | 0.0151346560256289 | LGG | Female-baised eQTL |
| rs10797396 | chr1:3481361:G:A | - | -0.0607038891185501 | 0.0186881816982485 | LGG | Female-baised eQTL |
| rs2821041 | chr1:3487663:C:T | - | 0.0589920516933401 | 0.0231071992643538 | LGG | Female-baised eQTL |
| rs1051515 | chr1:3480891:G:A | - | -0.0575567695769493 | 0.0321432161643924 | LGG | Female-baised eQTL |
| rs112449630 | chr1:4181027:G:A | - | 0.104334793677544 | 0.0336898017495957 | LGG | Female-baised eQTL |
| rs4281299 | chr1:4670900:T:C | - | 0.0957934302628234 | 0.0372904830678067 | LGG | Female-baised eQTL |
| rs11588149 | chr1:4665436:C:T | - | 0.0956431496056913 | 0.0377241124179731 | LGG | Female-baised eQTL |
| rs114168592 | chr1:4666933:C:T | - | 0.0955766849053083 | 0.0379482256495462 | LGG | Female-baised eQTL |
| rs116056075 | chr1:4663721:A:G | - | 0.0955398205958219 | 0.0380208730942416 | LGG | Female-baised eQTL |
| rs12083135 | chr1:4663782:G:A | - | 0.0955398205958219 | 0.0380208730942416 | LGG | Female-baised eQTL |
| rs1531831 | chr1:4662387:G:A | - | 0.0952548952417365 | 0.0393009937080818 | LGG | Female-baised eQTL |
| rs3748597 | chr1:953279:T:C | - | -0.0974538994411635 | 0.0435752996097732 | LGG | Female-baised eQTL |
| rs3748596 | chr1:953259:T:C | - | -0.0979652148968269 | 0.0486940019889807 | LGG | Female-baised eQTL |
| rs2298082 | chr1:3472709:T:C | - | -0.0543728662761825 | 0.0494934782933006 | LGG | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs77495751 | chr1:5026311:T:A | - | 0.0606857684539161 | 0.0289350661997327 | LGG | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg07946633 | |
| Position to Gene: promoter | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg01431482 | |
| Position to Gene: gene,enhancer | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg25618424 | |
| Position to Gene: gene,enhancer | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg11731671 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg25308086 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg00806481 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg22506548 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg24490279 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg23273418 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg24642064 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg21299491 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg23609682 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg09321238 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg01104489 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg12096707 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg08110058 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg16265140 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg21401095 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg24679453 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg22396632 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg22796923 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg24612696 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg17445936 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg05354921 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg15619820 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg04022097 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg22720392 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg23631759 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg09282201 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg03449456 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg12141662 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg19263228 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg17601209 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg20988960 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg26520908 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg13209113 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg17493795 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg26537941 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg25362585 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.47009332434938 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg22726349 | |
| Position to Gene: gene,enhancer | |
| Male Effect: - | |
| Female Effect: -0.231069937007169 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg01065697 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.2339822838622 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg04509221 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.171361186340709 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg04134748 | |
| Position to Gene: gene | |
| Male Effect: -0.354451550058496 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg07946633 | |
| Position to Gene: promoter | |
| Male Effect: -0.462849273223366 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg01431482 | |
| Position to Gene: gene,enhancer | |
| Male Effect: -0.462849273223366 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg22726349 | |
| Position to Gene: gene,enhancer | |
| Male Effect: -0.462849273223366 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg24460544 | |
| Position to Gene: gene | |
| Male Effect: -0.462849273223366 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg14966901 | |
| Position to Gene: gene | |
| Male Effect: -0.462849273223366 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg22729726 | |
| Position to Gene: gene | |
| Male Effect: -0.462849273223366 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg22122862 | |
| Position to Gene: gene,enhancer | |
| Male Effect: -0.304810994081099 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg01961086 | |
| Position to Gene: gene | |
| Male Effect: -0.215021061760058 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg14380230 | |
| Position to Gene: gene | |
| Male Effect: -0.248984900038863 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg27523417 | |
| Position to Gene: gene | |
| Male Effect: -0.186443150771204 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg20699701 | |
| Position to Gene: gene | |
| Male Effect: -0.0570925840855482 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg01647724 | |
| Position to Gene: gene | |
| Male Effect: -0.244037687783124 | |
| Female Effect: - | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg10100424 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.468498872073744 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg20671649 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.468498872073744 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg21475097 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.350613738126893 | |
 | Gene ID: ENSG00000142611 |
| CpG Site: cg10893986 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.0833488626747736 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg04134748 | chr1:3135611 | gene | -0.354451550058496 | 2.78661725483303e-37 | -0.6823497163087082 | 6.103918925634674e-41 | LGG |
| cg07946633 | chr1:3067681 | promoter | -0.462849273223366 | 5.37077708964226e-30 | -0.6304565293907805 | 1.9819572250953887e-33 | LGG |
| cg01431482 | chr1:3072521 | gene,enhancer | -0.462849273223366 | 5.37077708964226e-30 | -0.6304565293907805 | 1.9819572250953887e-33 | LGG |
| cg22726349 | chr1:3074114 | gene,enhancer | -0.462849273223366 | 5.37077708964226e-30 | -0.6304565293907805 | 1.9819572250953887e-33 | LGG |
| cg24460544 | chr1:3168882 | gene | -0.462849273223366 | 5.37077708964226e-30 | -0.6304565293907805 | 1.9819572250953887e-33 | LGG |
| cg14966901 | chr1:3183579 | gene | -0.462849273223366 | 5.37077708964226e-30 | -0.6304565293907805 | 1.9819572250953887e-33 | LGG |
| cg22729726 | chr1:3207290 | gene | -0.462849273223366 | 5.37077708964226e-30 | -0.6304565293907805 | 1.9819572250953887e-33 | LGG |
| cg22122862 | chr1:3071350 | gene,enhancer | -0.304810994081099 | 5.51362455776039e-25 | -0.5869061207374634 | 3.8312181715622294e-28 | LGG |
| cg01961086 | chr1:3169923 | gene | -0.215021061760058 | 2.52001456736094e-17 | -0.5073537654499198 | 3.027753487913819e-20 | LGG |
| cg14380230 | chr1:3198745 | gene | -0.248984900038863 | 2.84121257139161e-15 | -0.47996278846517115 | 4.660769722922112e-18 | LGG |
| cg27523417 | chr1:3101460 | gene | -0.186443150771204 | 1.68298677078746e-12 | -0.439524358061269 | 4.424802361960567e-15 | LGG |
| cg20699701 | chr1:3173198 | gene | -0.0570925840855482 | 2.62997235594318e-08 | -0.3547739927668645 | 5.362130203563567e-10 | LGG |
| cg01647724 | chr1:3140207 | gene | -0.244037687783124 | 5.83838017166664e-07 | -0.3328549101112451 | 6.622101638340722e-09 | LGG |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg07946633 | chr1:3067681 | promoter | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg01431482 | chr1:3072521 | gene,enhancer | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg25618424 | chr1:3072743 | gene,enhancer | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg11731671 | chr1:3079040 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg25308086 | chr1:3079456 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg00806481 | chr1:3080086 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg22506548 | chr1:3080385 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg24490279 | chr1:3080796 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg23273418 | chr1:3125895 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg24642064 | chr1:3140387 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg21299491 | chr1:3140802 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg23609682 | chr1:3154222 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg09321238 | chr1:3155437 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg01104489 | chr1:3155671 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg12096707 | chr1:3157150 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg08110058 | chr1:3157242 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg16265140 | chr1:3161642 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg21401095 | chr1:3162275 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg24679453 | chr1:3162505 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg22396632 | chr1:3162648 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg22796923 | chr1:3169945 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg24612696 | chr1:3173327 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg17445936 | chr1:3173781 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg05354921 | chr1:3183933 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg15619820 | chr1:3217199 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg04022097 | chr1:3217247 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg22720392 | chr1:3217293 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg23631759 | chr1:3227118 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg09282201 | chr1:3238597 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg03449456 | chr1:3274655 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg12141662 | chr1:3274674 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg19263228 | chr1:3275096 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg17601209 | chr1:3275114 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg20988960 | chr1:3275251 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg26520908 | chr1:3275312 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg13209113 | chr1:3356168 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg17493795 | chr1:3356843 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg26537941 | chr1:3380598 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg25362585 | chr1:3403867 | gene | -0.47009332434938 | 3.63946773859047e-31 | -0.9291580453232284 | 1.888997549282651e-35 | PAAD |
| cg22726349 | chr1:3074114 | gene,enhancer | -0.231069937007169 | 4.16508379508992e-08 | -0.6541874597382701 | 4.6925491419391215e-11 | PAAD |
| cg01065697 | chr1:3404174 | gene | -0.2339822838622 | 2.03191876323906e-07 | -0.617661959420595 | 1.0409302867325397e-09 | PAAD |
| cg04509221 | chr1:3238748 | gene | -0.171361186340709 | 1.07151507689541e-05 | -0.343337094926895 | 1.8261181853595297e-08 | LUAD |
| cg10100424 | chr1:3261820 | gene | -0.468498872073744 | 9.86720152166095e-71 | -0.8688167092448777 | 2.653695675088983e-74 | LGG |
| cg20671649 | chr1:3393300 | gene | -0.468498872073744 | 9.86720152166095e-71 | -0.8688167092448777 | 2.653695675088983e-74 | LGG |
| cg21475097 | chr1:3248078 | gene | -0.350613738126893 | 2.20061490180351e-40 | -0.7488421024506792 | 3.147401088287485e-44 | LGG |
| cg10893986 | chr1:3313175 | gene | -0.0833488626747736 | 2.73518344175949e-09 | -0.41254221456049955 | 3.083846859679776e-11 | LGG |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PRDM16 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000142611 | PRDM16 | C0007852 | Cervical Migraine Syndrome | 1 | CTD_human |
| ENSG00000142611 | PRDM16 | C0018984 | Hemicrania migraine | 1 | CTD_human |
| ENSG00000142611 | PRDM16 | C0149931 | Migraine Disorders | 1 | CTD_human |
| ENSG00000142611 | PRDM16 | C0270858 | Abdominal Migraine | 1 | CTD_human |
| ENSG00000142611 | PRDM16 | C0338489 | Status Migrainosus | 1 | CTD_human |
| ENSG00000142611 | PRDM16 | C0521664 | Acute Confusional Migraine | 1 | CTD_human |
| ENSG00000142611 | PRDM16 | C0700438 | Sick Headaches | 1 | CTD_human |
| ENSG00000142611 | PRDM16 | C3809288 | LEFT VENTRICULAR NONCOMPACTION 8 | 1 | CTD_human |
